Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Empesertib (BAY 1161909) is an orally bioavailable and selective inhibitor Mps1(IC50 < 1 nM), with potential antineoplastic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 139.00 | |
2 mg | In stock | $ 196.00 | |
5 mg | In stock | $ 322.00 | |
10 mg | In stock | $ 483.00 | |
25 mg | In stock | $ 789.00 | |
50 mg | In stock | $ 1,080.00 | |
100 mg | In stock | $ 1,490.00 | |
500 mg | In stock | $ 2,980.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 428.00 |
Description | Empesertib (BAY 1161909) is an orally bioavailable and selective inhibitor Mps1(IC50 < 1 nM), with potential antineoplastic activity. |
Targets&IC50 | Mps1:1 nM |
Synonyms | BAY 1161909 |
Molecular Weight | 559.61 |
Formula | C29H26FN5O4S |
CAS No. | 1443763-60-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (17.87 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Empesertib 1443763-60-7 Cytoskeletal Signaling Kinesin Inhibitor inhibit Mps1 BAY1161909 BAY 1161909 Monopolar spindle 1 BAY-1161909 inhibitor